But of more concern are the 700,000 invasive infections that can kill people, about half of which are caused by C. albicans. ...

Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...

A deadly fungal infection called 'Candida auris' is spreading ... has warned that more than one in three patients infected ...

Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with ...

Azole derivatives have been used as antifungal drugs in clinical practice for many years. However, limitations such as ...

Late-stage clinical investigation of ibrexafungerp for the treatment of life-threatening invasive fungal infections in hospitalized patients is ongoing. Additional antifungal assets from this ...

“It’s a promising result because most people who come to the hospital with invasive fungal infections are not going to be already on a keto diet,” Palmucci said. This doesn’t mean that the next time ...

The Phase 1 trial is a randomized, double-blind, placebo-controlled study of single and multiple ascending doses of oral SCY-247 in approximately 100 healthy subjects. The primary endpoint is safety ...

the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive fungal infections. “We are pleased to advance our potent, second-generation fungerp ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...